# NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
> **ANDA202250** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2015-07-08
## Drug
- **FDA Application Number:** ANDA202250
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
- **Generic name:** Nitrofurantoin
- **Active ingredients:** NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS INC
- **First approval:** 2015-07-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202250)
---
*MORVS · CC0 1.0*